Notes from Dr N Pettet regarding the meeting of Regional Transfusion Directors at BPL. Includes extensive details on the redevelopment of BPL updates on Factor 8Y and 9A and the cessation of previous generation Factor VIII products Clinical trial on 8Y Protocol and results of preliminary clinical trials update on Plasmapheresis Trials and HTLV-III Antibody testing.